Teresa L. Tinder - Concepedia

Concepedia

Author

Teresa L. Tinder

Mayo Clinic in Arizona

Also Known As

T L Tinder, T. Tinder, T.L. Tinder, Teresa L Tinder, Teresa L. Tinder, Teresa Tinder

49

Publications

1.6K

Citations

18

H-Index

45

Concepts

All Affiliations

Mayo Clinic in Arizona University of North Carolina at Charlotte Mayo Clinic Indiana University – Purdue University Indianapolis Carolinas Medical Center

TL

About

Teresa L. Tinder is an author at Mayo Clinic in Arizona specializing in medicine, immunology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	752
2	Cell Biology	6	6	635
3	Immunology	6	6	336
4	Natural Sciences	1	1	30
5	Microbiology	1	1	24

Teresa L. Tinder

×

18

Publications

1.6K

Citations

17

H-Index

	Year	Citations
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition Lopamudra Das Roy, Mahnaz Sahraei, Durai B. Subramani, Oncogene Tumor BiologyOncologyPancreatic CancerMedicinePancreatic Cancer Cells	2010	265
Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an <i>In vivo</i> Model of Spontaneous Metastatic Breast Cancer Gargi D. Basu, Latha Pathangey, Teresa L. Tinder, Molecular Cancer Research Breast OncologyApoptosisImmunologyCell DeathPathology	2004	151
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells Gargi D. Basu, Latha Pathangey, Teresa L. Tinder, Breast Cancer Research	2005	140
Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine: Role of IDO Gargi D. Basu, Teresa L. Tinder, Judy Bradley, The Journal of Immunology	2006	133
Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis Dahlia M. Besmer, Jennifer M. Curry, Lopamudra Das Roy, Cancer Research Profound DefectPancreatic CancerCell SignalingTumor GrowthGrowth Factor	2011	121
MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma Teresa L. Tinder, Durai B. Subramani, Gargi D. Basu, The Journal of Immunology	2008	111
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition Pinku Mukherjee, Gargi D. Basu, Teresa L. Tinder, The Journal of Immunology	2009	95
Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. Pinku Mukherjee, Cathy S. Madsen, Amelia R. Ginardi, Journal of Immunotherapy	2003	87
MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model Pinku Mukherjee, Latha Pathangey, Jillian Bradley, Vaccine Muc1-specific Immune TherapyStrong Anti-tumor ResponseCancer ImmunosurveillanceMedicineImmunology	2006	80
Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis Lopamudra Das Roy, Latha Pathangey, Teresa L. Tinder, Breast Cancer Research	2009	77

Page 1